2023 CTAD Poster

2023 CTAD Poster:

Recruitment and Eligibility of a Diverse Study Population in INTERCEPT-AD: A phase I trial of Aβ oligomer-targeting ACU193 in early Alzheimer’s disease.

2023 ADPD Poster

2023 ADPD Poster:

 

Binding of Soluble Amyloid Beta Oligomer Species to Human IPSC-derived Excitatory Neurons Assessed Using a Panel of AB Antibodies.

2023 AAIC Presentation

2023 AAIC Presentation:

 

Topline results of INTERCEPT-AD: A phase I trial of Aβ oligomer-targeting ACU193 in early Alzheimer’s disease.

2023 CTAD Presentation

2023 CTAD Presentation:

 

INTERCEPT-AD phase 1 insights and findings from the investigation of ACU193, a monoclonal antibody targeting soluble Aβ oligomers.

2023 CTAD Poster

2023 CTAD Poster:

 

INTERCEPT-AD: ACU193 CSF pharmacokinetics in early Alzheimer’s disease.

2023 CTAD Poster

2023 CTAD Poster:

 

Incorporating the Study Participant’s Voice into Early Development of ACU193 for Early Alzheimer’s Disease: A Qualitative Interview Study Following Participation in the INTERCEPT-AD Study.

2023 CTAD Poster

2023 CTAD Poster:

 

ACU193-sAβO Complex Measurement in CSF: Additional Analyses Using a Sensitive Assay of Target Engagement for the sAβO-Selective Antibody ACU193 in INTERCEPT-AD.